Vector Science & Therapeutics (TSXV: PAIN) ("Vector" or the "Company") today announced it has entered into an option agreement to purchase up to a 15% equity interest in LyoGenesis Plus for cash ...

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this ...

Vector Science & Therapeutics (TSXV: PAIN) ("Vector" or the "Company") today announced that it has entered into a development and manufacturing agreement with MPP Group LLC ("MPP"), a Mequon, ...

Vector Science & Therapeutics Corp. (TSXV: PAIN) ("Vector" or "Company") today announced the appointment of Dr. Alexander Dobranowski and Scott Kelly to its Board of Directors ("Board"), further ...

In the news release, Vector Science & Therapeutics Enters Three-Year Development and Manufacturing Agreement with MPP Group ...

ST. LOUIS--(BUSINESS WIRE)--Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, today announced the merger of its portfolio companies, Vector Laboratories and Absolute ...

Mequon-based Vector Science & Therapeutics announced that it has entered into an option agreement to purchase up to a 15% ...

Dr. Dobranowski is President, Director, and Co-Founder of HEALWELL AI, a leading healthcare artificial intelligence company focused on preventative care. With more than 15 years of clinical and ...